Domenico Ribatti
University of Bari
965 Papers
6.1K Citations
Domenico Ribatti is an academic researcher from University of Bari. The author has contributed to research in topics: Angiogenesis & Biology. The author has an hindex of 96, co-authored 913 publications. Previous affiliations of Domenico Ribatti include University of Genoa & National Institutes of Health.
Chat about Author
Papers
Angiogenesis in acute and chronic lymphocytic leukemia.
TL;DR: This review summarizes the literature concerning the relationship between angiogenesis and the progression of acute and chronic lymphocytic leukemia and applications of anti-angiogenic agents which interfere with or block leukemia progression are reviewed.
37
The contribution of Bruce Glick to the definition of the role played by the bursa of Fabricius in the development of the B cell lineage.
TL;DR: Bursa research increased considerably during the 1960s and early 1970s, and the demonstration that antibody responses are suppressed in the majority of bursectomized chickens became the cornerstone of modern immunology.
37
Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy
Luigi Manenti,E. Riccardi,Sergio Marchini,Elitza Naumova,Irene Floriani,Angela Garofalo,Romina Dossi,Eleonora Marrazzo,Domenico Ribatti,Eugenio Scanziani,Maria Rosa Bani,Dorina Belotti,Massimo Broggini,Raffaella Giavazzi +13 more
TL;DR: Plasma VEGF as a marker of tumor progression offers a valuable means of detecting early tumor response and following up treatments in an animal model.
37
Interleukin-30 Promotes Breast Cancer Growth and Progression
Irma Airoldi,Claudia Cocco,Carlo Sorrentino,Domenico Angelucci,Serena Di Meo,Lamberto Manzoli,Silvia Esposito,Domenico Ribatti,Maria Bertolotto,Laura Iezzi,Clara Natoli,Emma Di Carlo +11 more
TL;DR: Overall, the results show how IL30 regulates breast cancer cell viability, migration, and gene expression to promote breast cancer growth and progression and its impact on patient outcome.
The discovery of plasma cells: An historical note
TL;DR: Plasma cells are characterized by the co-expression of CD138 and CD38, which allows their identification in flow cytometry in bone marrow, peripheral blood, or cell suspensions from tissues, which paved the way for the development of monoclonal antibodies.
36